Jaypirca (pirtobrutinib tablets) — Cigna

Initial criteria

• Patient age ≥ 18 years AND
• Patient has tried at least one systemic chemotherapy regimen OR is not a candidate for chemotherapy AND
• Patient has tried one Bruton tyrosine kinase (BTK) inhibitor (e.g., Brukinsa [zanubrutinib], Calquence [acalabrutinib], Imbruvica [ibrutinib])

Approval duration

1 year